Page last updated: 2024-10-26

diphenyleneiodonium and Chronic Kidney Diseases

diphenyleneiodonium has been researched along with Chronic Kidney Diseases in 2 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Speer, T1
Owala, FO1
Holy, EW1
Zewinger, S1
Frenzel, FL1
Stähli, BE1
Razavi, M1
Triem, S1
Cvija, H1
Rohrer, L1
Seiler, S1
Heine, GH1
Jankowski, V1
Jankowski, J1
Camici, GG1
Akhmedov, A1
Fliser, D1
Lüscher, TF1
Tanner, FC1
Yisireyili, M1
Saito, S1
Abudureyimu, S1
Adelibieke, Y1
Ng, HY1
Nishijima, F1
Takeshita, K1
Murohara, T1
Niwa, T1

Other Studies

2 other studies available for diphenyleneiodonium and Chronic Kidney Diseases

ArticleYear
Carbamylated low-density lipoprotein induces endothelial dysfunction.
    European heart journal, 2014, Nov-14, Volume: 35, Issue:43

    Topics: Acetylcholine; Analysis of Variance; Animals; Aorta; Cardiovascular Diseases; Endothelium, Vascular;

2014
Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; Aorta; Cell Proliferation; Gene Expression Regulation; Humans; Indican; Muscle, Smooth, Vas

2014